M.Tech

Junior Research Fellow to work under the research project entitled Wastewater to biofuel and bio products : Cyanobacterial bio refinery through a green circular bio-economy.

Rational design, synthesis and evaluation of novel nitrogen-bearing heterocyclic hybrids as allosteric SH-2 domain- containing protein tyrosine phosphatase-2 inhibitors for cancer therapy. First class M.Pharm, MS Pharm, M. Tech in Pharmaceutical, Medicinal Chemistry with GATE, GPAT, CSIR UGC-NET qualification or equivalent examination.

Candidates should have experience in Biomedical Imaging, Biomedical signal processing, AI in health care etc. Expertise in developing and testing of Biomedical devices in class 2 and class 3 category will be an added advantage. Patent filed, granted in the area of biomedical devices will be preferred.

Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University AND Two years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services.

Masters of Science, Technology, Biotechnology from a recognised University.

Acquire an internationally recognized qualification from an Indian Institute of Eminence University and a top Australian university. Receive a full RMIT tuition fee scholarship for the duration of your enrollment. Receive a generous scholarship with nominal tuition fees from BITS.

M.Sc. in any branch of science e.g. Biology, Chemistry, Mathematics, Physics, M.Tech;, M B.B.S.. M.V.Sc.M.Pharm., Integrated M.Sc.. or equivalent qualification as per the norms of the Regional Centre For Biotechnology RCB, Faridabad, Haryana.

Candidates with more than two years of research experience in applied biology, biotechnology, drug screening, bioprospecting, microbiology, proteomics, mass- spectrometry or a related field of life sciences

The Project Research Scientist will perform experiments involving production of peptide-major histocompatibility complex peptide-MHC in bacterial andor mammalian expression systems, formulation of p-MHC tetramer, T-cell activation assay both in in-vitro/in-vivo set up, cancer cell culture, animal models for different types of tumors, and synthesis of nanoparticles.